Investor Conference Call on the planned acquisition of Merck’s Consumer Care business and our new Pharma sGC Cooperation

Tuesday, May 6, 2014
Start at approx. 1:00 p.m. CEST (11:00 a.m. UTC)

Bayer has agreed to acquire the consumer care business of U.S. pharmaceutical company Merck & Co., Inc. and to engage in a strategic pharma cooperation in the field of soluble guanylate cyclase (sGC) modulators. On this occasion we hosted a conference call for investors and analysts.


Dr. Marijn Dekkers
CEO of Bayer AG

Werner Baumann
CFO of Bayer AG

MP3 Audio Recording (presentation and discussion)

You can also play the audio recording on your mobile device.

Presentation charts
Download (PDF, 231 KB) collect
Transcript

Download (PDF, 175 KB) collect

Last updated: September 07, 2015 Copyright © Bayer AG